Societe D'Etudes De Recherches Et De Fabrication (SERF) – Trademark Portfolio
Entity Type: 99
Societe D'Etudes De Recherches Et De Fabrication (SERF) holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 5 filings in this category. The portfolio also extends into Class 20 (Furniture) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include SERF, XPEO, and NOVAE. The owner is based in Decines.
85 avenue des Bruyères
Decines 69150 , FR
Showing of trademarks Trademarks
Trademark Classifications
Societe D'Etudes De Recherches Et De Fabrication (SERF)'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Frequently Asked Questions
How many trademarks does Societe D'Etudes De Recherches Et De Fabrication (SERF) have?
Societe D'Etudes De Recherches Et De Fabrication (SERF) has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does Societe D'Etudes De Recherches Et De Fabrication (SERF) file in?
Societe D'Etudes De Recherches Et De Fabrication (SERF) files trademarks across 2 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 20 (Furniture). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Societe D'Etudes De Recherches Et De Fabrication (SERF)'s most well-known trademarks?
Societe D'Etudes De Recherches Et De Fabrication (SERF)'s registered trademark portfolio includes well-known marks such as SERF, XPEO, and NOVAE. These are among 3 currently registered trademarks in the portfolio.
What is Societe D'Etudes De Recherches Et De Fabrication (SERF)'s trademark registration success rate?
Societe D'Etudes De Recherches Et De Fabrication (SERF) has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.